CJC-1295 and Ipamorelin Combination Research: GHRH-GHRP Synergy, Somatotroph Signaling, and Preclinical Growth Hormone Evidence
Combined CJC-1295 and ipamorelin administration produces six- to ten-fold greater growth hormone release than either peptide alone through simultaneous GHRH-R and GHS-R1a activation. This review examines the molecular basis of dual-pathway somatotroph synergy, pharmacokinetic considerations, and current preclinical evidence.
Maple